Genmab A/SGNMSF
13F holders, Q2 2024 (June 30)1holders −1
0new positions
1sold out
$250.70avg. 13F price*
At the end of Q2 2024, 1 institutions reported holding Genmab A/S (GNMSF) in their 13F filings, down 1 from Q1 2024. 0 opened new positions and 1 sold out. The largest holder was Williams Jones Wealth Management, LLC. ($4.3M).
- Company
- Genmab A/S
- CUSIP
- K3967W102
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $221K |
All 13F filers, Q1 2024 → Q2 2024: 3,666 shares sold, net −3,666 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Williams Jones Wealth Management, LLC. | 0.05% | Reduce -17.2% | 17,176 | $4.3M |
"% of holder's portfolio" is GNMSF's weight in each manager's 13F, not the share of Genmab A/S the manager owns.